The effect of atrial natriuretic peptide on plasma renin activity, plasma aldosterone, and urinary dopamine in man

A. D. Struthers, J. V. Anderson, N. Payne, R. C. Causon, J. D. H. Slater, S. R. Bloom

    Research output: Contribution to journalArticlepeer-review

    15 Citations (Scopus)

    Abstract

    The acute natriuretic effect of human atrial natriuretic peptide (ANP) has been well described in man. We have now studied possible hormonal mediators of this effect. We studied six healthy volunteers on two occasions when they received either an infusion of ANP of 1.5 pmol X kg-1 X min-1 for 30 min followed by 15 pmol X kg-1 X min-1 for a further 30 min, or matching vehicle infusions in a randomized single-blind fashion. On the placebo day, plasma renin activity (PRA) rose from 1.26 +/- 0.08 to 1.57 +/- 0.14 ng A1 X ml-1 X h-1, while on the ANP study day PRA fell from 1.45 +/- 0.15 to 1.28 +/- 0.05 ng A1 X ml-1 X h-1 (p less than 0.01). No significant changes were found in plasma aldosterone concentrations or in urinary dopamine excretion. These results provide evidence that ANP suppresses renin release in man.
    Original languageEnglish
    Pages (from-to)223-226
    Number of pages4
    JournalEuropean Journal of Clinical Pharmacology
    Volume31
    Issue number2
    DOIs
    Publication statusPublished - 1986

    Fingerprint Dive into the research topics of 'The effect of atrial natriuretic peptide on plasma renin activity, plasma aldosterone, and urinary dopamine in man'. Together they form a unique fingerprint.

    Cite this